Home › Companies › DAY ONE BIOPHARMACEUTICALS INC. › 2023-2024
Compiled from SEC Form N-PX filings and DAY ONE BIOPHARMACEUTICALS INC.’s Form 8-K, filed May 24, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of May 23, 2024: 5 items on DAY ONE BIOPHARMACEUTICALS INC.’s Form 8-K, filed May 24, 2024: 5 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024 2024-2025
Explore DAY ONE BIOPHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are DAY ONE BIOPHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 24, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Jeremy Bender, Ph.D., M.B.A. | 62,935,239 | -- | -- | 11,080,216 | 4,390,159 | 85% | Not verified | — |
| Elect Director: Habib Dable, M.B.A. | 73,883,045 | -- | -- | 132,410 | 4,390,159 | 99.8% | Not verified | — |
| Elect Director: Saira Ramasastry, M.S., M.Phil. | 59,183,371 | -- | -- | 14,832,084 | 4,390,159 | 80% | Not verified | — |
| 2. The ratification of appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. | 78,312,286 | 91,361 | 1,967 | -- | -- | 99.8% | Not verified | — |
| 3. The approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. | 73,212,768 | 612,128 | 190,559 | -- | 4,390,159 | 99.1% | Not verified | — |
Source: DAY ONE BIOPHARMACEUTICALS INC., Form 8-K, filed with the SEC on May 24, 2024 — read the filing on EDGAR.
Each item below shows how the 174 asset managers that disclosed a DAY ONE BIOPHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of DAY ONE BIOPHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Habib Dable
DAY ONE BIOPHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Habib Dable, M.B.A.”): 73,883,045 for, 132,410 withheld, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,623,302 | 0 | 0 | 0 | For |
| BlackRock | 2,654,524 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 2,039,003 | 0 | 0 | 0 | For |
| Fidelity | 1,777,196 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,751,257 | 0 | 0 | 0 | For |
| State Street | 1,350,725 | 0 | 0 | 0 | For |
| Dimensional | 602,169 | 0 | 0 | 0 | For |
| Charles Schwab | 457,642 | 0 | 0 | 0 | For |
| Equitable | 175,282 | 0 | 0 | 0 | For |
| TIAA | 151,563 | 0 | 0 | 0 | For |
| AMG FUNDS | 137,900 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 131,714 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 111,530 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 110,000 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 91,858 | 0 | 0 | 0 | For |
| Lincoln Financial | 84,613 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 64,717 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,631 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 57,714 | 0 | 0 | 0 | For |
| ProShares | 45,154 | 0 | 0 | 0 | For |
| Tema ETF Trust | 44,423 | 0 | 0 | 0 | For |
| Brighthouse | 42,043 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 34,923 | 0 | 0 | 0 | For |
| Northern Trust | 34,181 | 0 | 0 | 0 | For |
| Global X | 33,901 | 0 | 0 | 0 | For |
Fund voting reports, all 57 managers: 17,030,072 for. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| TimesSquare Capital Management, LLC | 1,411,807 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 1,411,807 for.
Combines 4 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Jeremy Bender
DAY ONE BIOPHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jeremy Bender, Ph.D., M.B.A.”): 62,935,239 for, 11,080,216 withheld, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,623,302 | 0 | 0 | 0 | For |
| BlackRock | 2,654,524 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 2,039,003 | 0 | 0 | 0 | For |
| Fidelity | 1,777,196 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,751,257 | 0 | 0 | 0 | For |
| State Street | 1,348,881 | 0 | 0 | 1,844 | For |
| Dimensional | 0 | 0 | 0 | 602,169 | Withhold |
| Charles Schwab | 457,642 | 0 | 0 | 0 | For |
| Equitable | 175,282 | 0 | 0 | 0 | For |
| TIAA | 151,563 | 0 | 0 | 0 | For |
| AMG FUNDS | 137,900 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 131,714 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 111,530 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 110,000 | Withhold |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 91,858 | Withhold |
| Lincoln Financial | 51,700 | 0 | 0 | 32,913 | Mixed |
| RBB FUND, INC. | 13,255 | 0 | 0 | 51,462 | Mixed |
| ALPS ETF Trust | 0 | 0 | 0 | 61,631 | Withhold |
| Advisors' Inner Circle Fund III | 57,536 | 0 | 0 | 178 | For |
| ProShares | 0 | 0 | 0 | 45,154 | Withhold |
| Tema ETF Trust | 44,423 | 0 | 0 | 0 | For |
| Brighthouse | 21,771 | 0 | 0 | 20,272 | Mixed |
| Brinker Capital Destinations Trust | 2,218 | 0 | 0 | 32,705 | Mixed |
| Northern Trust | 34,181 | 0 | 0 | 0 | For |
| Global X | 33,901 | 0 | 0 | 0 | For |
Fund voting reports, all 57 managers: 15,683,812 for, 1,292,340 withheld, 53,920 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| TimesSquare Capital Management, LLC | 1,411,807 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 1,411,807 for.
Combines 4 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Saira Ramasastry
DAY ONE BIOPHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Saira Ramasastry, M.S., M.Phil.”): 59,183,371 for, 14,832,084 withheld, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 80% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,623,302 | 0 | 0 | 0 | For |
| BlackRock | 2,654,524 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 2,039,003 | 0 | 0 | 0 | For |
| Fidelity | 1,777,196 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,751,257 | 0 | 0 | 0 | For |
| State Street | 1,350 | 0 | 0 | 1,349,375 | Withhold |
| Dimensional | 0 | 0 | 0 | 602,169 | Withhold |
| Charles Schwab | 457,642 | 0 | 0 | 0 | For |
| Equitable | 112,282 | 0 | 0 | 63,000 | Mixed |
| TIAA | 151,563 | 0 | 0 | 0 | For |
| AMG FUNDS | 137,900 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 131,714 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 111,530 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 110,000 | Withhold |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 91,858 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 84,613 | Withhold |
| RBB FUND, INC. | 13,255 | 0 | 0 | 51,462 | Mixed |
| ALPS ETF Trust | 0 | 0 | 0 | 61,631 | Withhold |
| Advisors' Inner Circle Fund III | 57,714 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 45,154 | Withhold |
| Tema ETF Trust | 44,423 | 0 | 0 | 0 | For |
| Brighthouse | 21,771 | 0 | 0 | 20,272 | Mixed |
| Brinker Capital Destinations Trust | 0 | 0 | 0 | 34,923 | Withhold |
| Northern Trust | 34,181 | 0 | 0 | 0 | For |
| Global X | 33,901 | 0 | 0 | 0 | For |
Fund voting reports, all 57 managers: 14,210,609 for, 2,765,543 withheld, 53,920 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| TimesSquare Capital Management, LLC | 1,411,807 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 1,411,807 for.
Combines 6 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Description as filed by funds: Approval, on a non-binding advisory basis, of the compensation of our named executive officers.
DAY ONE BIOPHARMACEUTICALS INC.’s own tally for this item (“3. The approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers.”): 73,212,768 for, 612,128 against, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,623,302 | 0 | 0 | 0 | For |
| BlackRock | 2,654,524 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 2,039,003 | 0 | 0 | 0 | For |
| Fidelity | 1,777,196 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,751,257 | 0 | 0 | 0 | For |
| State Street | 1,350,725 | 0 | 0 | 0 | For |
| Dimensional | 602,169 | 0 | 0 | 0 | For |
| Charles Schwab | 457,642 | 0 | 0 | 0 | For |
| Equitable | 175,282 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 0 | 0 | 0 | 175,018 | Withhold |
| TIAA | 151,563 | 0 | 0 | 0 | For |
| AMG FUNDS | 137,900 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 131,714 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 111,530 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 110,000 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 91,858 | 0 | 0 | 0 | For |
| Lincoln Financial | 84,613 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 64,717 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,631 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 57,536 | 178 | 0 | 0 | For |
| ProShares | 45,154 | 0 | 0 | 0 | For |
| Tema ETF Trust | 44,423 | 0 | 0 | 0 | For |
| Brighthouse | 42,043 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 34,923 | 0 | 0 | 0 | For |
| Northern Trust | 34,181 | 0 | 0 | 0 | For |
Fund voting reports, all 58 managers: 17,017,345 for, 12,727 against, 175,018 withheld. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| New York Life | 14,000,000 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 7,747,198 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 3,732,355 | 0 | 0 | 0 | For |
| Fidelity | 3,007,329 | 0 | 0 | 0 | For |
| VIKING GLOBAL INVESTORS LP | 2,558,563 | 0 | 0 | 0 | For |
| State Street | 2,362,500 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,250,451 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 2,157,178 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,765,009 | 0 | 0 | 0 | For |
| BlackRock | 1,619,255 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 1,485,862 | 0 | 0 | 0 | For |
| TimesSquare Capital Management, LLC | 1,411,807 | 0 | 0 | 0 | For |
| Atlas Venture Life Science Advisors, LLC | 1,371,131 | 0 | 0 | 0 | For |
| Janus Henderson | 1,268,095 | 0 | 0 | 0 | For |
| Polar Capital Holdings Plc | 1,169,829 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 906,020 | 0 | 0 | 0 | For |
| MAVERICK CAPITAL LTD | 643,388 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 461,188 | 0 | 0 | 0 | For |
| Charles Schwab | 457,652 | 0 | 0 | 0 | For |
| Northern Trust | 303,374 | 52 | 0 | 0 | For |
| Candriam S.C.A. | 290,000 | 0 | 0 | 0 | For |
| Wellington | 242,679 | 0 | 0 | 0 | For |
| Samsara BioCapital, LLC | 196,425 | 0 | 0 | 0 | For |
| Nicholas Investment Partners, LP | 195,960 | 0 | 0 | 0 | For |
| NOMURA ASSET MANAGEMENT CO LTD | 0 | 184,668 | 0 | 0 | Against |
Institutional-manager reports, all 133 managers: 54,109,992 for, 314,683 against, 193 not voted, 26,675 1 year. Showing the 25 largest; see all in the interactive database.
Combines 4 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: Selection, on a non-binding advisory basis, of whether future advisory votes on the compensation of our named executive officers should be every one, two or three years.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| AMG FUNDS | 0 | 0 | 0 | 0 | -- |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| Delaware/Macquarie | 0 | 0 | 0 | 0 | -- |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| RBB FUND, INC. | 0 | 0 | 0 | 0 | -- |
| ALPS ETF Trust | 0 | 0 | 0 | 0 | -- |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| Tema ETF Trust | 0 | 0 | 0 | 0 | -- |
| Brighthouse | 0 | 0 | 0 | 0 | -- |
| Brinker Capital Destinations Trust | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 57 managers: 12,562 for, 16,397,296 1 year, 620,214 3 year. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| New York Life | 0 | 0 | 0 | 0 | -- |
| RA CAPITAL MANAGEMENT, L.P. | 0 | 0 | 7,747,198 | 0 | Abstain |
| FRANKLIN ADVISERS INC | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| VIKING GLOBAL INVESTORS LP | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| PICTET ASSET MANAGEMENT SA | 0 | 0 | 0 | 0 | -- |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| BRAIDWELL LP | 0 | 0 | 0 | 0 | -- |
| TimesSquare Capital Management, LLC | 0 | 0 | 0 | 0 | -- |
| Atlas Venture Life Science Advisors, LLC | 0 | 0 | 0 | 0 | -- |
| Janus Henderson | 0 | 0 | 0 | 0 | -- |
| Polar Capital Holdings Plc | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| MAVERICK CAPITAL LTD | 0 | 0 | 0 | 0 | -- |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | Not Voted |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Candriam S.C.A. | 0 | 0 | 0 | 0 | -- |
| Wellington | 0 | 0 | 0 | 0 | -- |
| Samsara BioCapital, LLC | 0 | 0 | 0 | 0 | -- |
| Nicholas Investment Partners, LP | 0 | 0 | 0 | 0 | -- |
| NOMURA ASSET MANAGEMENT CO LTD | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 129 managers: 77,313 for, 7,747,198 abstained, 193 not voted, 46,328,522 1 year, 97,364 3 year. Showing the 25 largest; see all in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024.
DAY ONE BIOPHARMACEUTICALS INC.’s own tally for this item (“2. The ratification of appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.”): 78,312,286 for, 91,361 against, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,623,302 | 0 | 0 | 0 | For |
| BlackRock | 2,654,524 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 2,039,003 | 0 | 0 | 0 | For |
| Fidelity | 1,777,196 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,751,257 | 0 | 0 | 0 | For |
| State Street | 1,350,725 | 0 | 0 | 0 | For |
| Dimensional | 602,169 | 0 | 0 | 0 | For |
| Charles Schwab | 457,642 | 0 | 0 | 0 | For |
| Equitable | 175,282 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 175,018 | 0 | 0 | 0 | For |
| TIAA | 151,563 | 0 | 0 | 0 | For |
| AMG FUNDS | 137,900 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 131,714 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 111,530 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 110,000 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 91,858 | 0 | 0 | 0 | For |
| Lincoln Financial | 84,613 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 64,717 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,631 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 57,714 | 0 | 0 | 0 | For |
| ProShares | 45,154 | 0 | 0 | 0 | For |
| Tema ETF Trust | 44,423 | 0 | 0 | 0 | For |
| Brighthouse | 42,043 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 34,923 | 0 | 0 | 0 | For |
| Northern Trust | 34,181 | 0 | 0 | 0 | For |
Fund voting reports, all 58 managers: 17,205,090 for. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| TimesSquare Capital Management, LLC | 1,411,807 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 1,411,807 for.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 87,389,859 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 5.29% |
| 2 | BlackRock | 3.04% |
| 3 | FRANKLIN STRATEGIC SERIES | 2.33% |
| 4 | Fidelity | 2.03% |
| 5 | T. Rowe Price | 2.00% |
| 6 | State Street | 1.55% |
| 7 | Dimensional | 0.69% |
| 8 | Charles Schwab | 0.52% |
| 9 | Equitable | 0.20% |
| 10 | Simplify Exchange Traded Funds | 0.20% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | New York Life | 16.02% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 8.87% |
| 3 | FRANKLIN ADVISERS INC | 4.27% |
| 4 | Fidelity | 3.44% |
| 5 | VIKING GLOBAL INVESTORS LP | 2.93% |
| 6 | State Street | 2.70% |
| 7 | T. Rowe Price | 2.58% |
| 8 | PICTET ASSET MANAGEMENT SA | 2.47% |
| 9 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.02% |
| 10 | BlackRock | 1.85% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| AI Day 1 LLC | 14.79% | DEF14A |
| FMR (Fidelity) | 11.55% | 13F |
| BlackRock | 10.30% | 13F |
| RA Capital Management, L.P. | 8.94% | DEF14A |
| Entities affiliated with Atlas Venture | 8.71% | DEF14A |
| Vanguard Group | 7.07% | 13F |
| Franklin Templeton | 4.36% | 13F |
| Jeremy Bender, Ph.D., M.B.A. | 3.65% | DEF14A |
| State Street | 3.31% | 13F |
| Samuel Blackman, M.D., Ph.D. | 2.81% | DEF14A |
Percentages above are of 87,389,859 shares outstanding, as reported by DAY ONE BIOPHARMACEUTICALS INC. on its Form 10-Q dated May 1, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from DAY ONE BIOPHARMACEUTICALS INC.’s 10-Q dated May 1, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At DAY ONE BIOPHARMACEUTICALS INC.'s shareholder meeting held May 23, 2024, in the 2023-2024 proxy season, 174 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,602 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on a non-binding advisory basis, of the compensation of our named executive officers. — FOR was 99.1% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: DAY ONE BIOPHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 24, 2024.
DAY ONE BIOPHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.
Download data (CSV): ballot items · votes by manager · column guide.